greatly. In patients in whom the disease has been active for many months the amount of 'y globulin is also increased. In pemphigus vulgaris chronicus the electrophoretic changes are similar but much less pronounced. Inasmuch as ACTH and cortisone have been proved to be of great value in the treatment of pemphigus, it was thought advisable to study the plasma proteins of patients with pemphigus before, during and after treatment with these drugs.
Since early 1950, seventeen patients with pemphigus have been treated at the Massachusetts General Hospital with ACTH or cortisone (2-4). The results have been very satisfactory. It has been possible to keep the disease under control in all patients by administering at intervals courses of either ACTH or cortisone in large doses.
The plasma proteins have been studied in 8 of these patients during a total of 13 courses. Four of the patients had pemphigus vulgaris acutus and showed on histologic examination intraepidermal bullae with acantholysis; two patients had pemphigus vulgaris chronicus with subepidermal bullae and no acantholysis; and 2 patients had pemphigus foliaceus. In addition to electrophoretic analysis, the plasma proteins were subjected to chemical fractionation in order to obtain additional information about the lipoproteins and glycoproteins present in the plasma.
METHODS
Collection of Blood For each determination 25.5 ml. of blood was drawn into a syringe containing 4.5 ml. of acid citrate dextrose solution (A.C.D.). The blood cells were removed by centrifugation to obtain the plasma, designated as "A.C.D. plasma", which was used for electrophoretic analysis, chemical fractionation and determination of plasma cholesterol and phospholipids.
The acid citrate dextrose solution used as anticoagulant contained per liter 26.7 g. trisodium citrate (5 1120), 8.0 g. citric acid monohydrate, and 22 g. dextrose. At the same time, approximately 10 ml. of blood was drawn with a dry syringe. Of this about 4 ml. was placed in a tube containing a small amount of heparin powder for determination of the total protein; 4 ml. was placed in a tube containing a small amount of potassium oxalate for the determination of fibrinogen; and 2 ml. was placed in a tube containing the dried residue of two drops of a solution of 2 per cent potassium oxalate and 3 per cent ammoniuni oxalate and was used for the determination of the sedimentation rate.
Electrophoresis
Electrophoretic analysis of the A.C.D. plasma was carried out in the Tiselius apparatus according to the technic described by Longsworth (5) . Sodium diethyl barbiturate-sodium citrate at pH 8.6 and an ionic strength of 0.1 was used as buffer. 
Chemical Fractionation
Chemical fractionation was carried out according to the method of Lever and coworkers (6) which represents an adaptation of Method 10 of plasma fractionation developed by Cohn and his associates (7) . Whereas the latter method is designed for fractionation of large quantities of plasma, the former represents a tool for analysis of certain of the protein components in small quantities of human plasma, requiring only 5 ml. of A.C.D. plasma for the analysis. The fractionation is carried out in a 5° C. bath using low concentrations of ethanol and various salts, resulting in the concentration of each protein component in an undenatured state almost exclusively in one fraction or another. In the present system of analysis the plasma has been separated by filtration into four fractions (Fig. 1) .
This method allows determination of albumin, present in Fraction IV+V; of y globulin, present as the only major component in Fraction II; of a-i lipoprotein, present in Fraction IV+V; and of j-1 lipoprotein, present in Fraction 1+111. In addition, the amounts of glycoprotein can be estimated by the determination of the amount of protein-bound carbohydrate (hexose) in each of the four fractions. The amount of hexose in Fraction VI represents a-i glycoprotein; the amount of hexose in Fraction IV+V corresponds to a-2 glycoprotein, since neither albumin nor a-i lipoprotein contain any hexose; and the amount of hexose in Fraction 1+ III represents largely the $ glycoproteins. Fibrinogen determinations were carried out on plasma rather than on Fraction 1+111.
cx-l Glycoprotein Analytic Methods
All analytic determinations, with the exception of the fibrinogen and the sedimentation rate, were carried out on A.C.D. plasma or its fractions. Since it was realized that the addition of A.C,D. tothe blood as anticoagulant resulted in an unknown degree of dilution, a nitrogen determination was carried out on plasma from heparinized blood as well as on A.C.D. plasma. The factor (N in heparinized plasma / N in A.C.D. plasma) has been applied to all data obtained on A.C.D. plasma and the various fractions.
Total Nitrogen was determined by the micro-Kjeldahl method. Non-protein nitrogen was determined after precipitation of the proteins with 20 per cent trichloracetic acid.
Total plasma protein, as used for the conversion of the relative electrophoretic values into absolute values, was calculated by multiplying the protein nitrogen value obtained on heparinized blood by 6.73. The factor of 6.73, rather than the more commonly used value of 6.25, was applied in order to include into the calculations not only the peptide moieties but also the lipid moieties of the lipoproteins. The contribution of the protein-bound lipids to the eleetrophoretic pattern is nearly equal to that of a corresponding weight of protein (8) .
Albumin was determined in Fraction IV+V+VI by the hemin-binding method of Rosenfeld and Surgenor (9) .
y Globulin was calculated by determination of total protein in Fraction II with the biuret reaction. For the biuret reaction a modification of the method of Mehl (10) by Lever and coworkers (6) was used. Since Fraction II contains more than 90 per cent of the y globulin in a purity exceeding 90 per cent by electrophoretic measurements, the amount of total protein in Fraction II was assumed to represent the amount of yglobulin quite accurately.
Lipid analyses were carried out on ethanol extracts of the plasma and of the fractions. Total cholesterol was determined by the method of Bloor, Pelkan and Allan (11) . Lipid phosphorus was determined by the method of Fiske and SubbaRow (12) following the ashing procedure of Gortner (13 Hexose was determined in the four fractions according to a modification of the method of Sørensen and Haugaard (16) introduced by Friedman (17) . The presence of free carbohydrate (glucose) prevented determination of hexose in whole plasma. Inasmuch as the percentage of hexose in the various glycoproteins is not yet known the exact quantity of the various glycoproteins could not be calculated. Nevertheless, changes in the hexose content of the various fractions can be interpreted as representing changes in the amount of glycoprotein.
Fibrino yen was determined according to the method of Cullen and Van Slyke (18) . The nitrogen value obtained on the clotted protein with the micro-Kjeldahl method was multiplied by the factor 6.0.
Sedimentation rate determinations were carried out according to the method of Wintrobe and Landsberg (19) . The values obtained were corrected to apply to a hematocrit value of 45 per cent.
RESTJLTS
Total Protein and Electrophoretic Analysis of Plasma The changes in the total plasma protein concentration and in the electrophoretic components prior to therapy with ACTII or cortisone were similar to those reported previously (1) . The changes were, however, less pronounced due to the fact that most patients were placed on treatment before the disease had reached an advanced stage. 3.26 4.73 .64
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. 20 .42 . Electrophoretic Analysis. Before treatment the albumin was below normal in all instances (Table 1) . Very low values, between 1.5 and 2.8 grams per 100 ml., were obtained in 4 patients. (These are the same patients as those in whom the total plasma protein was significantly lowered.) The a-i globulin was considerably elevated in most patients. Amounts greater than 0.6 grams per 100 ml. were A a 02 Pu The first pattern was obtained before treatment; the second pattern was obtained after sixteen days of treatment with ACTII (300 mg. a day i.m. for fourteen days, and 200 mg. a day i.m. for two days); the third pattern was obtained two months after termination of treatment. During and following treatment the albumin increased from a very low to a nearly normal value, while the a-i and a-2 globulin decreased from elevated to normal values. (For exact data see Table I , patient 2, determinations 1, 2 and 4).
found in 5 patients. (The normal average value is 0.38 grams per 100 ml.). The a-2 globulin was moderately increased in the majority of patients. The 3-1 globulin showed no significant changes before treatment. The 3-2 globulin (which in normal plasma consists to approximately equal parts of /3-2 globulin and fibrinogen and averages 0.61 grams per 100 ml.) was elevated above 0.75 grams in 3 of the 8 patients. Since the amount of /3-2 globulin is not significantly altered in the serum of patients with pemphigus (1), it can be assumed that the increase in /3-2 globulin observed in the plasma of patients with pemphigus was due largely to an increase in the amount of fibrinogen. The value for ' globulin was normal in 4, slightly elevated in 2, and moderately elevated (above 1 gram per 100 ml.) in 2 patients.
Treatment with ACTH or cortisone produced the following changes: The albumin rose (Fig. 2 ) in all but 1 patient; however, a normal value of 4 grams per 100 ml. was attained in only 2 patients. The value for a-i globulin decreased during treatment in 5 of the 8 patients, but was still significantly elevated at the end of treatment in several patients. Similarly, the a-2 globulin showed a tendency to decrease. The $-1 globulin did not change significantly under treatment. The 9-2 globulin components, which contains the fibrinogen, decreased in all patients in whom it had been elevated except in 1 (Patient 3). In 3 patients (Patients 6, 7 and 8) it fell to subnormal levels, namely 0.37, 0.43 and 0.46 grams per 100 ml. of plasma, as compared with a normal average value of 0.61 grams. They globulin decreased under treatment in all but 1 patient (Patient 4 who had received treatment for only 20 days). At the end of treatment the 'y globulin was still slightly elevated in 3, normal in 3, and below normal in 2. In the latter 2 patients (Patients 1 and 8 ) the y globulin decreased from normal values of 0.74 and 0.81 grams per 100 ml. to 0.47 and 0.53 grams per 100 ml., respectively.
Chemical Fractionation of Plasma
Albumin, 'y Globulin. The values for albumin and y globulin obtained by chemical fractionation corresponded, on the whole, quite closely to the values obtained by electrophoretic analysis (Table 1) .
Hexose. The amount of protein-bound sugar, or hexose, indicates the amount of glycoprotein present. Prior to therapy the total amount of hexose in the plasma (calculated on the amount present in all four fractions) was greatly increased in all patients ( Table 2) . Study of the amount of hexose in the various fractions revealed that the increase was confined entirely to Fractions IV + V and VI, which contain the a-2 glycoprotein and the a-i glycoprotein, respectively. The average hexose content in Fraction IV + V before treatment was 97 mg. per 100 ml. (which is more than twice the normal average amount of 45 mg. per 100 ml.); while in Fraction VI the average amount was 33 mg. per 100 ml. (which is twice the normal average amount of 15 mg. per 100 ml.). The values for hexose in Fraction I + III, representing largely the 3 glycoproteins, were within normal limits.
Under treatment the amount of a-i glycoprotein decreased in 5 patients, and the amount of a-2 glycoprotein decreased in 4 patients. Nevertheless, the values for the two a glycoproteins remained significantly elevated in most patients. The amount of glycoproteins remained within normal limits.
Fibrinogen. The values for fibrinogen (Table 1) were elevated prior to treatment in all patients. The increase was considerable in 3 patients, amounting to values above 0.5 grams per 100 ml., as compared with a normal average value of 0.29 grams.
Under treatment the fibrinogen decreased in 6 patients, while in 2 it remained elevated above a value of 0.5 grams per 100 ml. In 3 patients the amount of The total cholesterol values in the plasma before treatment were within normal limits in 6 of the 8 patients (Table 2) . A low value, 121 mg. per 100 ml., was found in a patient who was very ill with advanced pemphigus vulgaris acutus (Patient 2). One patient with pemphigus foliaceus and essential hypertension (Patient 7) had hypercholesteremia of 315 mg. per 100 ml. This high value probably was not related to the pemphigus foliaceus. The amounts of cholesterol in Fractions I + III (fl-i lipoprotein) and IV + V (a-i lipoprotein) were within normal limits in all patients except the 2 patients with hypocholesteremia and hypercholesteremia, respectively.
Under treatment the plasma cholesterol increased in 5 patients, showed no essential change in 1, and decreased in 2. The average level rose from 198 to 22i mg. per 100 ml. Temporary hypercholesteremia was induced in 2 patients: in 1 patient the total cholesterol rose during one course from 194 to 303 mg. per 100 ml., and in the other from 178 to 318 mg. per 100 ml. (Patients 1 and 5) . Of the two lipoprotein-containing fractions, Fraction I + III, representing fl-i lipoprotein, showed no significant change in cholesterol under treatment. In Fraction IV + V, however, representing a-i lipoprotein, a considerable increase in cholesterol occurred during treatment, from an average of 61 to 88 mg. per 100 ml. An increase occurred in all patients but 1 (Patient i). In this patient, however, a determination ten days after cessation of therapy revealed a substantial rise of the cholesterol level in Fraction IV + V from 55 mg. per 100 ml. at the end of treatment to 86 mg.
In order to ascertain how long the increase in cholesterol in Fraction IV + V persisted, determinations were carried out at varying intervals after cessation of therapy. As shown in Table 3 , a substantial increase in the amount of cholesterol in Fraction IV + V following cessation of therapy was noted in 2 patients after ten and forty-three days, respectively, whereas a fall of the cholesterol value was noted in 7 determinations and no essential change in 2. A comparison of the values obtained some time after the last treatment with those obtained before treatment showed that there was no tendency of ACTII or cortisone to induce a persistent increase of the cholesterol in Fraction IV + V.
The values for total plasma phospholipids paralleled those for cholesterol closely. Before treatment the values were normal in all patients except the patient with essential hypertension (Patient 7) who had an elevated value. The * The assumption is made that the percentage of cholesterol in a-i and -i lipoprotein remains constant even when the amount of cholesterol is increased. That this is a fact remains to be proven. amount of phospholipids in Fraction I + III (-1 lipoprotein) and IV + V (a-i lipoprotein) were also normal in all patients but Patient 7.
Under treatment the total plasma phospholipids increased in amount in 4 patients, showed no essential change in 2, and decreased in 2. The average level rose from 222 to 234 mg. per 100 ml. Of the two lipoprotein fractions, Fraction I + III, the 3-1 lipoprotein fraction, showed no significant change in the amount of phospholipids under treatment. In Fraction IV + V, however, the a-i lipoprotein fraction, a significant increase in the phospholipids occurred in 4 patients, TABLE 3 Value of cholesterol in Fraction IV + V (a-i lipo protein) before treatment with ACTH or cortisone, at end of treatment, and following an interval without treatment and no essential change in 4. The average value rose from 117 to 138 mg. per 100 ml.
Calculation of the values for a-i and 3-i lipoproteins on the basis of their cholesterol content revealed under treatment a considerable increase in the average value for a-i lipoprotein from 0.38 to 0.55 grams per 100 ml. of plasma. No significant change occurred in the average value for 3-1 lipoprotein.
Sedimentation Rate
The sedimentation rate before treatment was elevated in all patients and, corrected to a hematocrit value of 45 per cent, averaged 1.1 mm. per minute, as compared with a normal value of 0.2 mm. The sedimentation rate decreased under treatment in all patients. The average sedimentation rate after treatment was 0.55 mm. per minute (Table 1) . DISCUSSION The most important electrophoretic findings before treatment were a marked decrease in albumin, and an increase in a-i globulin, a-2 globulin, fl-2 globulin and y globulin (Figure 3) . Chemical fractionation studies revealed a considerable increase in the a-i and a-2 glycoproteins, suggesting that the increase in the electrophoretic a-i and a-2 globulin components was due to an increase in glycoprotein. The values for the a-i and fl-i lipoproteins were normal. Corre- (n = normal; (+) = slightly increased; + = moderately increased; ++ = greatly increased; -= moderately decreased; --= greatly decreased.) sponding to the increase in the electrophoretic fl-2 globulin component there was a significant increase in fibrinogen on chemical analysis.
Under treatment with ACTH or cortisone all abnormal values showed a shift in the direction of normal; but the values did not reach normal in all patients while treatment was administered. Especially the values for the a-i and a-2 globulins on electrophoretic analysis and for the a-i and a-2 glycoproteins on chemical analysis tended to remain elevated. It should be noted, however, that in Patient 2 in whom the disease remained fully under control for several months after the last treatment a further shift of the electrophoretic values for a-i and a-2 globulin toward normal occurred (Figure 2 ). Even then, however, the value for a-2 glycoprotein was still elevated indicating that this glycoprotein is very slow in returning to a normal value.
It is likely that in most plasma protein components the shift toward normal under treatment with AUTH or cortisone is not a direct effect of these drugs, but is brought about indirectly through improvement of the disease by the drugs. There were three proteins, however, on which AUTH and cortisone appeared to exert a direct effect, namely 'y globulin, fibrinogen and a-i lipoprotein.
Globulin. The y globulin, which decreased under treatment in all but 1 patient in spite of the tendency of the disease to induce a rise of the y globulin, fell in 4 of the 8 patients either during or at the end of one of the courses to values below normal (Patients 1, 2, 7 and 8 high values was observed in all patients receiving AUTH or cortisone. Both the cholesterol and the phospholipid content of the a-i lipoprotein increasod. In contrast, the j3-1 lipoprotein remained essentially unchanged. The increase in the a-i lipoprotein continued in 2 patients for some time after discontinuance of therapy, but in all other patients the value for a-i lipoprotein decreased after cessation of therapy, usually to pretreatment levels.
That AUTH and cortisone have an effect on the lipid metabolism has been noted by several observers. Uonn, Vogel, Louis and Fajans (24) who administered short courses of AUTH lasting from six to nine days to 3 normal men observed a significant decrease in total cholesterol, especially in the esterified fraction, between the third and fifth days. On the other hand, Adlersberg, Schaeffer and Drachman (25) who administered AUTH or cortisone over long periods of time found, as we have observed, an elevation of both the cholesterol and the phospholipids in 36 out of 47 courses. This increase occurred more often in patients receiving long courses extending over sixty days than in patients treated with short courses. Hypercholesteremia with values above 280 mg. per 100 ml. of plasma developed during 7 of the 8 long courses. The increase in cholesterol concerned both the free and esterified fraction so that the ratio between the two fractions remained undisturbed. Sprague and coworkers (26) found an increase in the total plasma cholesterol during the administration of cortisone in 4 out of 6 patients. The conclusion that can be drawn from these observations is that immediately after or within the first few days of treatment with ACTH or cortisone the cholesterol may fall, but that prolonged administration is liable to induce a rise in serum cholesterol and phospholipids.
The reason for the increase in a-i lipoprotein observed by us in all patients under treatment with ACTH or cortisone is obscure. Preliminary studies carried out in this laboratory on patients with disturbances of the lipid metabolism have revealed that in nephrosis, biliary cirrhosis, myxedema, primary familial xanthomatosis and essential hyperlipemia the increase in lipoprotein is confined to the 3-i lipoprotein and that in some of the patients with these diseases, especially those with nephrosis, the a-i lipoprotein is actually decreased in amount.
Sedimentation Rates. Correlation of the sedimentation rates with the electrophoretic and fractionation data revealed no absolute relationship with any one component. Nevertheless, the best correlation existed with the $-2 globulin component of the electrophoretic pattern (which contains the fibrinogen) and with the fibrinogen as determined by chemical analysis. As a rule, the sedimentation rate decreased as the amount of fibrinogen decreased. However, in several patients the sedimentation rate was found to be elevated although the fibrinogen revealed normal values. In such patients the a-globulin values were still elevated (Patient 3, determinations 2 and 4; Patient 8, determination 1). Thus, high values for the a globulins seemed to accelerate the sedimentation rate. In addition, a low value for albumin tended to be associated with a high sedimentation rate. No correlation, however, was noted with y globulin. In several patients the sedimentation rate was low while globulin was elevated (Patient 1, determination 2;
Patient 5, determination 2; Patient 6, determination 2).
SUMMARY
Electrophoretic and chemical fractionation studies of the plasma proteins were carried out on patients with pemphigus before and after treatment with ACTH or cortisone.
Before treatment, electrophoretic studies revealed: a decrease in albumin and an increase in the a-i, a-2, 3-2 and y globulin. Chemical fractionation studies revealed that the increase in the electrophoretic a-i and a-2 globulin components was due to a considerable increase in the a-i and a-2 glycoproteins; and that the increase in the electrophoretic 3-2 component was due to an increase in fibrinogen. The a-i lipoprotein increased from normal to abnormally high values in all patients while treatment with ACTH or cortisone was administered. The fl-i lipoprotein, on the other hand, remained normal. The elevated values for a-i lipoprotein decreased to normal in most patients within a few weeks after treatment with ACTH or cortisone was discontinued. DISCUSSION DR. BLANK, Philadelphia: I wondered if these changes which you described with ACTH or cortisone are also seen in patients, with other diseases, who received these drugs, or are some of these changes with the drugs specific for patients with pemphigus. DR. LEVER: In answer to Dr. Blank's question: The changes which I have described are not specific for pemphigus. Other severe cutaneous diseases, such as generalized exfoliative dermatitis, reveal the same pattern, namely: a marked decrease in albumin and an increase in the alpha glycoproteins, in fibrinogen and in gamma globulin. These deviations decrease on treatment with ACTH or cortisone.
The increase in alpha lipoprotein which I described is not in any way due to pemphigus. It is brought about by the treatment with ACTH or cortisone and occurs also in other diseases when treated with these drugs.
